4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0001231947-14-000002
CIK 0000899866operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:03 PM ET
Size
13.5 KB
Accession
0001231947-14-000002
Insider Transaction Report
Form 4
MADRI JOSEPH A
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2014-03-11$8.18/sh+30,000$245,400→ 209,217 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-03-11$10.84/sh+30,000$325,200→ 239,217 total - Sale
Common Stock, par value $.0001 per share
2014-03-11$178.35/sh−50,000$8,917,500→ 189,217 total - Sale
Common Stock, par value $.0001 per share
2014-03-11$179.88/sh−10,000$1,798,800→ 179,217 total - Exercise/Conversion
Option to Purchase Common Stock
2014-03-11$8.18/sh−30,000$245,400→ 0 totalExercise: $8.18From: 2006-09-07Exp: 2016-06-07→ Common Stock, par value $.0001 per share (30,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2014-03-11$10.84/sh−30,000$325,200→ 0 totalExercise: $10.84From: 2007-08-03Exp: 2017-05-03→ Common Stock, par value $.0001 per share (30,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $178.00 - $178.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $179.00 - $179.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:03 PM ET
- Size
- 13.5 KB